Advertisement

Endocrine

, Volume 63, Issue 1, pp 157–163 | Cite as

The relationship between anti-Müllerian hormone serum level and body mass index in a large cohort of infertile patients

  • Dragos Albu
  • Alice Albu
Original Article
  • 98 Downloads

Abstract

Purpose

To evaluate the relationship between serum Anti-Müllerian hormone (AMH) level and body mass index (BMI) in infertile patients.

Methods

Medical records of patients with infertility evaluated between January 2013 and February 2018 in the Reproductive Medicine Department of a private hospital were reviewed. Patients with the following criteria were excluded from the study: polycystic ovary syndrome, primary ovarian insufficiency, AMH values > 10 ng/mL, current oral contraceptive users and previous ovarian surgery or endometriosis, and anovulation of other causes, except decreased ovarian reserve.

Results

A total of 2204 infertile patients were included (mean age 34.58 ± 4.3 years, mean BMI 22.35 ± 3.6 kg/m2, and mean serum AMH 2.44 ± 2.17 ng/ml). In the entire group of patients, serum AMH level was positively correlated with BMI after adjustment for age (beta = 0.059, p < 0.005). When the association between serum AMH level and BMI was analysed in subgroups of patients, after adjustment for age, we found a positive correlation between the two parameters in patients ≤ 35 years old (< 0.05), of normal weight (p < 0.05) and with normal ovarian reserve (p < 0.05). After adjustment for age, BMI ≥ 25 kg/m2 was significantly associated with higher AMH values in comparison to normal weight patients.

Conclusions

In infertile patients, AMH is positively correlated with BMI, especially in patients younger than 35 years, of normal weight and with normal ovarian reserve. Moreover, the presence of mild excess adiposity seems to be associated with higher AMH values. Our data contradict the previous studies showing a negative impact of excess adiposity on AMH serum levels.

Keywords

Anti-Müllerian hormone Body mass index Infertility Obesity Adiposity 

Notes

Acknowledgements

We are grateful to all of the staff working in the Maternal-foetal and Reproductive Medicine Department of Medlife

Compliance with ethical standards

Conflict of interest

D.A. has received travel grants from Merck, Merck Sharp & Dohme and Ferring Pharmaceuticals. A.A. has received travel grants from Ferring Pharmaceuticals, Pfizer and a speaker honourarium from Sandoz Pharma Services.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

References

  1. 1.
    R.L. Cate, R.J. Mattaliano, C. Hession, R. Tizard, N.M. Farber, A. Cheung, E.G. Ninfa, A.Z. Frey, D.J. Gash, E.P. Chow, R.A. Fisher, J.M. Bertonis, G. Torres, B.P. Wallner, K.L. Ramachandran, R.C. Ragin, T.F. Manganaro, D.T. MacLaughlin, P.K. Donahoe, Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cell 45, 685–698 (1986)CrossRefGoogle Scholar
  2. 2.
    K.R. Hansen, G.M. Hodnett, N. Knowlton, L.B. Craig, Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil. Steril. 95, 170–175 (2011)CrossRefGoogle Scholar
  3. 3.
    A.Z. Steiner, F.Z. Stanczyk, S. Patel, A. Edelman, Antimullerian hormone and obesity: insights in oral contraceptive users. Contraception 81, 245–248 (2010)CrossRefGoogle Scholar
  4. 4.
    S.L. Broer, B.W. Mol, D. Hendriks, F.J. Broekmans, The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil. Steril. 91, 705–714 (2009)CrossRefGoogle Scholar
  5. 5.
    E.W. Freeman, C.R. Gracia, M.D. Sammel, H. Lin, L.C. Lim, J.F. Strauss, 3rd Association of antimullerian hormone levels with obesity in late reproductive-age women. Fertil. Steril. 87, 101–106 (2007)CrossRefGoogle Scholar
  6. 6.
    H.I. Su, M.D. Sammel, E.W. Freeman, H. Lin, T. DeBlasis, C.R. Gracia, Body size affects measures of ovarian reserve in late reproductive age women. Menopause 15, 857–861 (2008)CrossRefGoogle Scholar
  7. 7.
    M. Olszanecka-Glinianowicz, P. Madej, A. Owczarek, J. Chudek, P. Skalba, Circulating anti- Mullerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome. Clin. Endocrinol. 83, 98–104 (2015)CrossRefGoogle Scholar
  8. 8.
    H.T. Park, G.J. Cho, K.H. Ahn, J.H. Shin, Y.T. Kim, J.Y. Hur, S.H. Kim, K.W. Lee, T. Kim, Association of insulin resistance with anti-Mullerian hormone levels in women without polycystic ovary syndrome (PCOS). Clin. Endocrinol. 72, 26–31 (2010)CrossRefGoogle Scholar
  9. 9.
    S. Sahmay, T. Usta, C.T. Erel, M. Imamoglu, M. Kucuk, N. Atakul, H. Seyisoglu, Is there any correlation between amh and obesity in premenopausal women? Arch. Gynecol. Obstet. 286, 661–665 (2012)CrossRefGoogle Scholar
  10. 10.
    S. Halawaty, E. ElKattan, H. Azab, N. ElGhamry, H. Al-Inany, Effect of obesity on parameters of ovarian reserve in premenopausal women. J. Obstet. Gynaecol. 32, 687–690 (2010)Google Scholar
  11. 11.
    M. Dolleman, W.M. Verschuren, M.J. Eijkemans, M.E. Dolle, E.H. Jansen, F.J. Broekmans, Y.T. van der Schouw, Reproductive and lifestyle determinants of anti-Mullerian hormone in a large population-based study. J. Clin. Endocrinol. Metab. 98, 2106–2115 (2013)CrossRefGoogle Scholar
  12. 12.
    J. Dupont, M. Reverchon, L. Cloix, P. Froment, C. Ramé, Involvement of adipokines, AMPK, PI3K and the PPAR signaling pathways in ovarian follicle development and cancer. Int. J. Dev. Biol. 56, 959–967 (2012)CrossRefGoogle Scholar
  13. 13.
    Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 81(1), 19–25 (2004)CrossRefGoogle Scholar
  14. 14.
    A.P. Ferraretti, A. La Marca, B.C.J.M. Fauser, B. Tarlatzis, G. Nargund, L. Gianarolion, on behalf of the ESHRE working group on Poor Ovarian Response Definition: ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Human. Reprod. 26(7), 1616–1624 (2011)CrossRefGoogle Scholar
  15. 15.
    WHO. Physical Status: The Use and Interpretation of Anthropometry. Report of a WHO Expert Committee. (World Health Organization, Geneva, 1995).Google Scholar
  16. 16.
    M.R. Sowers, D. McConnell, M. Yosef, M.L. Jannausch, S.D. Harlow, J.F. Randolph Jr., Relating smoking, obesity, insulin resistance, and ovarian biomarker changes to the final menstrual period. Ann. N.Y. Acad. Sci. 1204, 95–103 (2010)CrossRefGoogle Scholar
  17. 17.
    B.L. Wajchenberg, J.A. Marcondes, M.B. Mathor, S.S. Achando, O.A. Germak, M.A. Kirschner, Free testosterone levels during the menstrual cycle in obese versus normal women. Fertil. Steril. 51, 535–537 (1989)CrossRefGoogle Scholar
  18. 18.
    E. Buyuk, D.B. Seifer, E. Illions, R.V. Grazi, H. Lieman, Elevated body mass index is associated with lower serum anti-mullerian hormone levels in infertile women with diminished ovarian reserve but not with normal ovarian reserve. Fertil. Steril. 95, 2364–2368 (2011)CrossRefGoogle Scholar
  19. 19.
    L.A. Bernardi, M.R. Carnethon, P.J. de Chavez, D.E. Ikhena, L.M. Neff, D.D. Baird, E.E. Marsh, Relationship between obesity and anti-Müllerian hormone in reproductive-aged African American women. Obesity. 25, 229–235 (2017)CrossRefGoogle Scholar
  20. 20.
    J. Simões-Pereira, J. Nunes, A. Aguiar, S. Sousa, C. Rodrigues, J. Sampaio Matias, C. Calhaz-Jorge, Influence of body mass index in anti-Müllerian hormone levels in 951 non-polycystic ovarian syndrome women followed at a reproductive medicine unit. Endocrine (2018).  https://doi.org/10.1007/s12020-018-1555-y.
  21. 21.
    A. La Marca, E. Spada, V. Grisendi, C. Argento, E. Papaleo, S. Milani, A. Volpe, Normal serum anti-Mullerian hormone levels in the general female population and the relationship with reproductive history. Eur. J. Obstet. Gynecol. Reprod. Biol. 163, 180–184 (2012)CrossRefGoogle Scholar
  22. 22.
    S. Jung, N. Allen, A.A. Arslan, L. Baglietto, L.A. Brinton, B.L. Egleston, R. Falk, R.T. Fortner, K.J. Helzlsouer, A. Idahl, R. Kaaks, E. Lundin, M. Merritt, C. Onland-Moret, S. Rinaldi, M.J. Sanchez, S. Sieri, H. Schock, X.O. Shu, P.M. Sluss, P.N. Staats, R.C. Travis, A. Tjønneland, A. Trichopoulou, S. Tworoger, K. Visvanathan, V. Krogh, E. Weiderpass, Zeleniuch-Jacquotte, W. Zheng, J.F. Dorgan, Demographic, lifestyle, and other factors in relation to antimullerian hormone levels in mostly late premenopausal women. Fertil. Steril. 107, 1012–1022.e2 (2017)CrossRefGoogle Scholar
  23. 23.
    I.A. van Rooij, F.J. Broekmans, G.J. Scheffer, C.W. Looman, J.D. Habbema, F.H. de Jong, B.J. Fauser, A.P. Themmen, E.R. te Velde, Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil. Steril. 83, 979–987 (2005)CrossRefGoogle Scholar
  24. 24.
    Y. Fu, X. Zheng, L. Bao, K. Xu, X. Cheng, M. Sun, X. Xue, H. Chen, T. Yang, M. Zhang, Assessment of physiological factors for the establishment of serum insulin reference intervals in healthy Chinese Han adults: a community-based large cross-sectional study. Scand. J. Clin. Lab. Invest. 75, 319–326 (2015)CrossRefGoogle Scholar
  25. 25.
    L. Cui, Y. Qin, X. Gao, J. Lu, L. Geng, L. Ding, Z. Qu, X. Zhang, Z.J. Chen, Antimüllerian hormone: correlation with age and androgenic and metabolic factors in women from birth to postmenopause. Fertil. Steril. 105, 481–485.e1 (2016)CrossRefGoogle Scholar
  26. 26.
    L.G. Nardo, A.P. Yates, S.A. Roberts, P. Pemberton, I. Laing, The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome. Hum. Reprod. 24, 2917–2923 (2009)CrossRefGoogle Scholar
  27. 27.
    C.Y. Andersen, K. Lossl, Increased intrafollicular androgen levels affect human granulosa cell secretion of anti-Müllerian hormone and inhibin-B. Fertil. Steril. 89, 1760–1765 (2008)CrossRefGoogle Scholar
  28. 28.
    C. Bergh, B. Carlsson, J.H. Olsson, U. Selleskog, T. Hillensjö, Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin. Fertil. Steril. 59, 323–331 (1993)CrossRefGoogle Scholar
  29. 29.
    S. Ledoux, D.B. Campos, F.L. Lopes, M. Dobias-Goff, M.F. Palin, B.D. Murphy, Adiponectin induces periovulatory changes in ovarian follicular cells. Endocrinology 147, 5178–5186 (2006)CrossRefGoogle Scholar
  30. 30.
    Y. Arita, S. Kihara, N. Ouchi, M. Takahashi, K. Maeda, J. Miyagawa, K. Hotta, I. Shimomura, T. Nakamura, K. Miyaoka, H. Kuriyama, M. Nishida, S. Yamashita, K. Okubo, K. Matsubara, M. Muraguchi, Y. Ohmoto, T. Funahashi, Y. Matsuzawa, Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. 1999. Biochem. Biophys. Res. Commun. 425, 560–564 (2012)CrossRefGoogle Scholar
  31. 31.
    C. Chabrolle, L. Tosca, C. Ramé, P. Lecomte, D. Royère, J. Dupont, Adiponectin increases insulin-like growth factor I-induced progesterone and estradiol secretion in human granulosa cells. Fertil. Steril. 92, 1988–1996 (2009)CrossRefGoogle Scholar
  32. 32.
    L. Cheng, H. Shi, Y. Jin, X. Li, J. Pan, Y. Lai, Y. Lin, Y. Jin, G. Roy, A. Zhao, F. Li, Adiponectin deficiency leads to female subfertility and ovarian dysfunctions in mice. Endocrinology 157, 4875–4887 (2016)CrossRefGoogle Scholar
  33. 33.
    W.F. Zeng, Y. Li, C.S. Sheng, Q.F. Huang, Y.Y. Kang, L. Zhang, S. Wang, Y.B. Cheng, F.K. Li, J.G. Wang, Association of anthropometric and bioelectrical impedance analysis measures of adiposity with high molecular weight adiponectin concentration. PLoS One 11, e0156041 2016).CrossRefGoogle Scholar
  34. 34.
    S. Kallio, J. Puurunen, A. Ruokonen, T. Vaskivuo, T. Piltonen, J.S. Tapanainen, Antimüllerian hormone levels decrease in women using combined contraception independently of administration route. Fertil. Steril. 99, 1305–1310 (2013)CrossRefGoogle Scholar
  35. 35.
    J.G. Bentzen, J.L. Forman, A. Pinborg, Ø. Lidegaard, E.C. Larsen, L. Friis-Hansen, T.H. Johannsen, A. Nyboe. Andersen, Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception. Reprod. Biomed. Online 25, 612–619 (2012).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.“Carol Davila” University of Medicine and PharmacyBucharestRomania
  2. 2.Maternal-foetal and Reproductive Medicine DepartmentMedlifeBucharestRomania
  3. 3.Endocrinology and Diabetes DepartmentElias HospitalBucharestRomania

Personalised recommendations